Related Experiment Video
Updated: Nov 8, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue
1Division of Plastic and Reconstructive Surgery, Stellenbosch University and Tygerberg Academic Hospital, Cape Town, South Africa.
Objective:
Binding to angiotensin-converting enzyme 2 (ACE2) receptor is a critical step for severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) to mediate its entry into target cells. ACE2 is expressed in many human tissues, including the lungs. However, no research has demonstrated that SARS-CoV-2 can infect human breast tissue. This study aimed to investigate ACE2 gene expression in human breast tissue using a public database.
Materials And Methods:
A search of a public gene expression database was performed to investigate ACE2 gene expression in in human breast tissue.
Results:
The gene expression profile demonstrated that ACE2 gene expression was higher in human breast tissue than human lung tissue.
Conclusion:
Our knowledge about coronavirus disease-2019 (COVID-19) is expanding rapidly. Clinicians are eager for vetted information regarding all aspects of this new illness, and this study demonstrates that the level of ACE2 expression in human breast tissue is higher than that in the lung tissue, a major target tissue affected by SARS-CoV-2 infection. This finding strongly suggests that SARS-CoV-2 infection causes breast pathology.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses the angiotensin-converting enzyme 2 (ACE2) receptor for cell entry. This study found higher ACE2 gene expression in human breast tissue than lung tissue, suggesting potential SARS-CoV-2 infection of the breast.
Area of Science:
- Virology
- Genomics
- Pathology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into host cells depends on binding to the angiotensin-converting enzyme 2 (ACE2) receptor.
- ACE2 receptors are present in various human tissues, including the lungs, a primary target for SARS-CoV-2.
- Previous research has not confirmed SARS-CoV-2 infection in human breast tissue.
Purpose of the Study:
- To investigate the expression of the ACE2 gene in human breast tissue.
- To compare ACE2 gene expression levels in breast tissue with those in lung tissue.
Main Methods:
- Utilized a public gene expression database.
- Performed a search to identify and analyze ACE2 gene expression data in human breast tissue samples.
Main Results:
- ACE2 gene expression was detected in human breast tissue.
- The expression level of the ACE2 gene was found to be higher in human breast tissue compared to human lung tissue.
Conclusions:
- The elevated ACE2 expression in breast tissue suggests it could be a potential target for SARS-CoV-2.
- This finding implies that SARS-CoV-2 infection may lead to pathology in breast tissue.
- Further research is warranted to understand the implications of ACE2 expression in breast tissue concerning COVID-19.
Related Concept Videos
Cell Specific Gene Expression
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Regulation of Angiogenesis and Blood Supply

